Valuation: Linc AB

Market Cap 4.29B 451M 390M 366M 333M 627M 43.17B 637M 1.68B 21.62B 1.7B 1.66B 71.84B P/E 2024
3.84x
P/E 2025 -10.1x
Enterprise Value 4.01B 422M 364M 342M 311M 585M 40.32B 595M 1.57B 20.19B 1.58B 1.55B 67.09B EV / Sales 2024
3.45x
EV / Sales 2025 -9.06x
Free-Float
36.64%
Yield 2024 *
-
Yield 2025 -
1 day+0.13%
1 week+0.95%
Current month+0.13%
1 month+4.51%
3 months+3.06%
6 months+15.58%
Current year+6.46%
1 week 72.8
Extreme 72.8
75
1 month 71.7
Extreme 71.7
76.7
Current year 58.9
Extreme 58.9
78.1
1 year 58.9
Extreme 58.9
81.3
3 years 52.2
Extreme 52.2
103.4
5 years 43.8
Extreme 43.8
103.4
10 years 43.8
Extreme 43.8
118.2
Manager TitleAgeSince
Chief Executive Officer 52 2019-12-31
Director of Finance/CFO 44 2019-12-31
Director TitleAgeSince
Chairman 73 1990-12-31
Director/Board Member 52 2019-12-31
Director/Board Member 60 2019-12-31
Date Insider Type Main position Quantity % Market Cap.
8/6/26 Buy

Chief Executive Officer

5,000 0.0086%
2/25/26 Buy

Director

31,000 0.0535%
2/25/26 Buy

Director

19,000 0.0328%
Change 5-day change 1-year change 3-year change Capi.($)
+0.13%+0.95%-7.71%+9.28% 451M
-0.64%-0.64%+13.97%-2.52% 164M
Average -0.26%-0.36%+3.13%+3.38% 307.54M
Weighted average by Cap. -0.07%+0.06%-1.94%+6.14%

Financials

2024 2025
Net sales 1.29B 136M 117M 110M 100M 188M 12.98B 192M 505M 6.5B 510M 499M 21.61B -414M -43.53M -37.6M -35.33M -32.13M -60.41M -4.16B -61.41M -162M -2.08B -163M -160M -6.93B
Net income 1.3B 137M 118M 111M 101M 190M 13.09B 193M 509M 6.55B 514M 503M 21.78B -400M -42.03M -36.3M -34.11M -31.02M -58.32M -4.02B -59.28M -156M -2.01B -158M -154M -6.69B
Net Debt -550M -57.8M -49.92M -46.91M -42.66M -80.21M -5.53B -81.53M -215M -2.77B -217M -212M -9.2B -284M -29.86M -25.79M -24.24M -22.04M -41.44M -2.86B -42.12M -111M -1.43B -112M -110M -4.75B
Logo Linc AB
Linc AB is a Sweden-based investment company. Linc invests in product-oriented companies within the Nordic Life Science industry - primarily in pharmaceutical and medical technology companies. The investments are made in both private and public companies and in research and operational companies. Typically, investments in drug development take place in an earlier phase compared to investments in medical technology. Linc Invest is an active and long-term owner with a wide industrial network to support the portfolio companies. The Company works together with the management, founders and board to realize the inherent potential that exists in the investment, have ambitious plans for further development and expansion and actively participate in the nomination committee work.
Employees
2
Date Price Change Volume
26-08-14 SEK 74.20 +0.13% 16,765
26-08-13 SEK 74.10 -0.13% 16,247
26-08-12 SEK 74.20 +0.82% 12,197
26-08-11 SEK 73.60 +0.55% 21,398
26-08-10 SEK 73.20 -0.41% 14,336
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
1
Last Close Price
74.20SEK
Average target price
72.00SEK
Spread / Average Target
-2.96%
  1. Stock Market
  2. Stocks
  3. LINC Stock